Hyper Spectral Insight
Hyper Spectral Insight
  • Home
  • Our Solutions
  • Technology
  • Product
  • About Us
  • Contact Us
  • More
    • Home
    • Our Solutions
    • Technology
    • Product
    • About Us
    • Contact Us
  • Home
  • Our Solutions
  • Technology
  • Product
  • About Us
  • Contact Us
data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=

For successful Breast Cancer Surgeries The Rainbow Probe

For successful Breast Cancer Surgeries The Rainbow ProbeFor successful Breast Cancer Surgeries The Rainbow ProbeFor successful Breast Cancer Surgeries The Rainbow Probe


NuTek is the First Prize Winner  

Of  Merage Institute +45 Startups Competition 2020 










For successful Breast Cancer Surgeries The Rainbow Probe

For successful Breast Cancer Surgeries The Rainbow ProbeFor successful Breast Cancer Surgeries The Rainbow ProbeFor successful Breast Cancer Surgeries The Rainbow Probe


NuTek is the First Prize Winner  

Of  Merage Institute +45 Startups Competition 2020 










Breast Cancer Surgeries

“About 1 of 8 U.S women will develop invasive

breast cancer over the course of her lifetime.”

(breastcancer.org).


About 2,000,000 Breast Cancer Operations are performed

world-wide, each year.


Incomplete cancerous tumor removal is the main cause for

up to 60% repeated surgeries.

NuTek’s Rainbow probe enables complete tumor removal. 

It detects residual cancerous tissue on patient’s body.

The Impact we ought to prevent

 Breast Cancer incomplete tumor removal

could be a life changer for patients.


Preventing reoperation, means hope for new life.




The Rainbow Probe value proposition

Significant reduction in all parameters:

Patients

  • Re-operation Need
  • Recovery Time
  • Recurrence Probability

Hospitals

  • Operation Time
  • Variability among Surgeons & Institutions

Insurance and Payers

  • Reoperations economical burden - $5.5B/y, in the US only 


Copyright © 2020 

Dov Cohen, Founder & Executive Chairman NUTEK Ltd.